Regulatory authorities in Japan have approved Sanofi’s oral therapy Wayrilz (rilzabrutinib) for treating people with immune thrombocytopenia…
Articles by Marisa Horak, MS
Dangerous blood clots that block blood flow are rare in people with von Willebrand disease (VWD), but their risk…
Symptoms unrelated to bleeding, such as fatigue and mental health struggles, are common among people with immune thrombocytopenia (ITP)…
A mutation in the gene ELF4 likely set the stage for a teenage boy to develop immune thrombocytopenia (ITP), according…
Two teenage brothers in Egypt have been diagnosed with an extremely rare combination of two distinct genetic blood-clotting disorders. The…
Regulatory authorities in Brazil have approved the oral therapy Tavalisse (fostamatinib disodium hexahydrate)Â for…
Spleen tyrosine kinase (SYK) inhibitors, including Tavalisse (fostamatinib disodium hexahydrate), may be effective treatments for…
The case of a woman with von Willebrand disease type 1 who developed a ruptured brain aneurysm was described…
Pharma companies Galapagos and Gilead are in talks for a potential collaboration to develop gamgertamig, an experimental therapy…
Celebrities and advocacy groups are teaming up to raise awareness of bleeding disorders with a three-hour livestream celebrating the community.